Australia markets closed

Sino Biopharmaceutical Limited (SBHMY)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
6.780.00 (0.00%)
At close: 01:45PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
26,199,409
26,199,409
26,026,164
26,861,356
23,647,224
-
Cost of revenue
4,989,877
4,989,877
4,487,616
5,332,095
5,182,320
-
Gross profit
21,209,532
21,209,532
21,538,548
21,529,261
18,464,904
-
Operating expenses
Research development
4,402,973
4,402,973
4,164,498
-
2,626,709
2,398,712
Selling general and administrative
11,066,635
11,066,635
11,708,780
12,703,627
11,628,561
-
Total operating expenses
15,423,818
15,423,818
16,058,744
17,175,600
14,160,755
-
Operating income or loss
5,785,714
5,785,714
5,479,804
4,353,661
4,304,149
-
Interest expense
495,237
495,237
429,494
308,617
323,368
-
Income before tax
5,409,906
5,409,906
5,214,869
18,572,673
5,013,044
-
Income tax expense
797,267
797,267
696,716
1,957,880
672,377
-
Income from continuing operations
4,612,639
4,612,639
4,518,153
16,614,793
4,340,667
-
Net income
2,331,939
2,331,939
2,543,570
14,608,412
2,771,086
-
Net income available to common shareholders
2,543,134
2,543,134
2,311,200
14,125,901
2,771,086
-
Basic EPS
2.03
2.52
2.72
15.57
2.95
-
Diluted EPS
1.95
2.52
2.43
14.65
2.95
-
Basic average shares
928,746
926,453
931,112
938,432
940,014
-
Diluted average shares
936,896
928,754
950,860
964,148
940,014
-